Pharmaceutical

Anavex Life Sciences Announces Encouraging Preliminary Biomarker Results from Ongoing Phase 2 Study of ANAVEX®3-71 for the Treatment of Schizophrenia

Part A of the placebo-controlled Phase 2 study has been completed ANAVEX®3-71 demonstrates a dose-dependent pharmacodynamic effect on objective EEG...

Theratechnologies Unveils Study Design and Baseline Characteristics of PROMISE-US Trial of Ibalizumab in Heavily Treatment-Experienced People with HIV and Multidrug Resistance

Travere Therapeutics and CSL Vifor Announce Swissmedic Approval of FILSPARI® (sparsentan) for the Treatment of IgA Nephropathy

Temporary marketing authorization is based on statistically significant and clinically meaningful results from the Phase 3 PROTECT TrialSAN DIEGO, Oct....

Psyence Biomed Provides Progress Update on PsyLabs E.U. Good Manufacturing Practices (GMP) Certified Active Pharmaceutical Ingredient (API) Development

PsyLabs to exclusively supply Psyence Biomed with high purity, pharmaceutical grade psilocybin for its second development indication, Alcohol Use Disorder,...

AscellaHealth Announces its Strategic Acquisition of CHAPPER healthcare: Expands Global Specialty Pharmaceutical Wholesale and Product Distribution Services

BERWYN, Pa. and WATFORD, United Kingdom, Oct. 17, 2024 (GLOBE NEWSWIRE) -- AscellaHealth, a global partner delivering customizable solutions to...

Iktos appoints new Scientific Advisory Board with world-renowned AI and Drug Discovery experts to accelerate the development of novel therapies

Iktos appoints new Scientific Advisory Board with world-renowned AI and Drug Discovery experts to accelerate the development of novel therapies...

Redox Adds HITRUST i1 Certification for its Google Cloud Offering to Manage Healthcare Data Protection and Mitigate Cybersecurity Threats

HITRUST Certification Validates Redox is Operating Leading Security Practices to Protect Sensitive Healthcare Information MADISON, Wis., Oct. 16, 2024 /PRNewswire/...

error: Content is protected !!